16223396

Source:http://linkedlifedata.com/resource/pubmed/id/16223396

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002771, umls-concept:C0022742, umls-concept:C0027396, umls-concept:C0032790, umls-concept:C0186193, umls-concept:C0439810, umls-concept:C1176415, umls-concept:C1696465, umls-concept:C1707455
pubmed:issue	10
pubmed:dateCreated	2005-10-14
pubmed:abstractText	Lumiracoxib is a novel selective cyclooxygenase-2 (COX-2) inhibitor in development for the treatment of chronic and acute pain.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370270
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Analgesics, Opioid, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2 Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Diclofenac, http://linkedlifedata.com/resource/pubmed/chemical/Morphine, http://linkedlifedata.com/resource/pubmed/chemical/Naproxen, http://linkedlifedata.com/resource/pubmed/chemical/Organic Chemicals, http://linkedlifedata.com/resource/pubmed/chemical/lumiracoxib
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0001-5172
pubmed:author	pubmed-author:ChanV W SVW, pubmed-author:ClarkA JAJ, pubmed-author:DavisJ CJC, pubmed-author:JayawardeneSS, pubmed-author:KellsteinDD, pubmed-author:WolfR SRS
pubmed:issnType	Print
pubmed:volume	49
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1491-500
pubmed:dateRevised	2009-11-6
pubmed:meshHeading	pubmed-meshheading:16223396-Adolescent, pubmed-meshheading:16223396-Adult, pubmed-meshheading:16223396-Aged, pubmed-meshheading:16223396-Aged, 80 and over, pubmed-meshheading:16223396-Analgesics, Opioid, pubmed-meshheading:16223396-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:16223396-Arthroplasty, Replacement, Hip, pubmed-meshheading:16223396-Arthroplasty, Replacement, Knee, pubmed-meshheading:16223396-Cyclooxygenase 2 Inhibitors, pubmed-meshheading:16223396-Diclofenac, pubmed-meshheading:16223396-Double-Blind Method, pubmed-meshheading:16223396-Female, pubmed-meshheading:16223396-Humans, pubmed-meshheading:16223396-Male, pubmed-meshheading:16223396-Middle Aged, pubmed-meshheading:16223396-Morphine, pubmed-meshheading:16223396-Naproxen, pubmed-meshheading:16223396-Organic Chemicals, pubmed-meshheading:16223396-Pain, Postoperative, pubmed-meshheading:16223396-Pain Measurement, pubmed-meshheading:16223396-Sample Size
pubmed:year	2005
pubmed:articleTitle	The post-operative analgesic efficacy and tolerability of lumiracoxib compared with placebo and naproxen after total knee or hip arthroplasty.
pubmed:affiliation	Department of Anesthesia and Pain Management, Toronto Western Hospital, University Health Network, Toronto, ON, Canada. vincent.chan@uhn.on.ca
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study